Global Gene Therapy Market 2022-2028

Report Format: PDF   |   Report ID: 5652420   |   Published Date: December 2022   |   Pages:  72  

Choose License
According to  the global gene therapy market is set to achieve an incremental growth of USD 11.6 billion, acelerating at a CAGR of almost 23.7% during the forecast period 2022-2028.
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global gene therapy market. It traces the market's historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors' approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the gene therapy industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the indication, technology, and region. The global market for gene therapy can be segmented by indication: cancer, metabolic disorder, eye disorder, spinal muscular atrophy, others. Globally, the cancer segment made up the largest share of the gene therapy market. Gene therapy market is further segmented by technology: adeno virus vector, adeno-associated virus vector, lentiviral vector, retroviral vector, herpes virus vector, others. The adeno virus vector segment captured the largest share of the market in 2021. Based on region, the gene therapy market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, North America had the largest share in the global gene therapy market.
Market Segmentation
By indication: cancer, metabolic disorder, eye disorder, spinal muscular atrophy, others
By technology: adeno virus vector, adeno-associated virus vector, lentiviral vector, retroviral vector, herpes virus vector, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report also provides a detailed analysis of several leading gene therapy market vendors that include Abeona Therapeutics Inc., Amgen Inc., Astellas Pharma Inc., Biogen, bluebird bio, Inc., Editas Medicine Inc., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics plc, REGENXBIO Inc., Roche Holding AG, Sibiono GeneTech Co., Ltd., UniQure N.V., Voyager Therapeutics Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
- To analyze and forecast the market size of the global gene therapy market.
- To classify and forecast the global gene therapy market based on indication, technology, region.
- To identify drivers and challenges for the global gene therapy market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global gene therapy market.
- To identify and analyze the profile of leading players operating in the global gene therapy market.
Why Choose This Report
- Gain a reliable outlook of the global gene therapy market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
?? Report description
?? Objectives of the study
?? Market segment
?? Years considered for the report
?? Currency
?? Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
?? Introduction
?? Drivers
?? Restraints
?? Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY INDICATION
?? Cancer
?? Metabolic disorder
?? Eye disorder
?? Spinal muscular atrophy
?? Others
PART 6. MARKET BREAKDOWN BY TECHNOLOGY
?? Adeno virus vector
?? Adeno-associated virus vector
?? Lentiviral vector
?? Retroviral vector
?? Herpes virus vector
?? Others
PART 7. MARKET BREAKDOWN BY REGION
?? North America
?? Europe
?? Asia-Pacific
?? MEA (Middle East and Africa)
?? Latin America
PART 8. KEY COMPANIES
?? Abeona Therapeutics Inc.
?? Amgen Inc.
?? Astellas Pharma Inc.
?? Biogen
?? bluebird bio, Inc.
?? Editas Medicine Inc.
?? Generation Bio Co.
?? Gilead Sciences Inc.
?? Novartis AG
?? Orchard Therapeutics plc
?? REGENXBIO Inc.
?? Roche Holding AG
?? Sibiono GeneTech Co., Ltd.
?? UniQure N.V.
?? Voyager Therapeutics Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

This GCC report is based on the synthesis, analysis, and interpretation of information about the global market collected from specialized sources. GCC analysts have derived insights using a mix of primary and secondary research with an aim to provide a holistic picture of the market. The research methodology used to estimate and forecast the market begins with capturing data on key players’ revenues in the market through secondary research. The bottom-up procedure was employed to obtain the overall market size of the global market. Specific to this market, global market volume & revenue is estimated on the basis of the sales information of key major players.  
 

After arriving at the overall market size, the industry is then divided into several segments and sub-segments which are then verified through primary research by conducting extensive interviews with key people such as CEOs, sales managers, Directors and executives. Drawing on GCC’s research, expert interviews, and extensive experience working with market-facing companies worldwide, main trends that have begun- and will most likely continue-to affect this industry are identified and analyzed.

Publisher: Gen Consulting Company